Epstein-Barr virus: 40 years on (Q29617969)

Europe PubMed Central

title

Epstein-Barr virus: 40 years on (English)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15510157

30 April 2017

0 references

0 references

Alan Bernard Rickinson

series ordinal

2

object named as

Rickinson AB

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15510157

30 April 2017

author name string

Young LS

series ordinal

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15510157

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15510157

30 April 2017

language of work or name

1 reference

30 April 2017

publication date

October 2004

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15510157

30 April 2017

published in

Nature Reviews Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15510157

30 April 2017

volume

4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15510157

30 April 2017

issue

10

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15510157

30 April 2017

page(s)

757-68

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15510157

The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold

30 April 2017

cites work

1 reference

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

1 May 2017

1 reference

Structure and coding content of CST (BART) family RNAs of Epstein-Barr virus

1 May 2017

1 reference

Crystal structure of LpxC, a zinc-dependent deacetylase essential for endotoxin biosynthesis

1 May 2017

1 reference

T cell leukemia I oncogene expression depends on the presence of Epstein-Barr virus in the virus-carrying Burkitt lymphoma lines

1 May 2017

1 reference

Aids-related malignancies

1 May 2017

1 reference

NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells

1 May 2017

1 reference

Dual stimulation of Epstein-Barr Virus (EBV)-specific CD4+- and CD8+-T-cell responses by a chimeric antigen construct: potential therapeutic vaccine for EBV-positive nasopharyngeal carcinoma

1 May 2017

1 reference

A role for SKIP in EBNA2 activation of CBF1-repressed promoters

1 May 2017

1 reference

VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA

1 May 2017

1 reference

Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus

31 March 2020

1 reference

Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells

31 March 2020

1 reference

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

31 March 2020

1 reference

Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes

31 March 2020

1 reference

CD8 T cell recognition of endogenously expressed epstein-barr virus nuclear antigen 1

31 March 2020

1 reference

Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1.

31 March 2020

1 reference

Epstein-Barr virus provides a survival factor to Burkitt's lymphomas

31 March 2020

1 reference

Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes

31 March 2020

1 reference

Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation

31 March 2020

1 reference

The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein

31 March 2020

1 reference

Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2.

31 March 2020

1 reference

EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus.

31 March 2020

1 reference

Epstein-Barr virus EBNA3C can disrupt multiple cell cycle checkpoints and induce nuclear division divorced from cytokinesis.

31 March 2020

1 reference

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

31 March 2020

1 reference

Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation

31 March 2020

1 reference

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

31 March 2020

1 reference

Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production

31 March 2020

1 reference

Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors

31 March 2020

1 reference

Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.

31 March 2020

1 reference

Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor

31 March 2020

1 reference

Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses

31 March 2020

1 reference

LMP1 structure and signal transduction

31 March 2020

1 reference

Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?

31 March 2020

1 reference

Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals

31 March 2020

1 reference

Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt.

31 March 2020

1 reference

Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma

31 March 2020

1 reference

Epstein-Barr virus LMP2A interferes with global transcription factor regulation when expressed during B-lymphocyte development

31 March 2020

1 reference

The role of EBERs in oncogenesis.

31 March 2020

1 reference

Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma

31 March 2020

1 reference

Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis

31 March 2020

1 reference

EBV gene expression in an NPC-related tumour.

31 March 2020

1 reference

Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells

31 March 2020

1 reference

Expression of a family of complementary-strand transcripts in Epstein-Barr virus-infected cells

31 March 2020

1 reference

N-terminal domain of BARF1 gene encoded by Epstein-Barr virus is essential for malignant transformation of rodent fibroblasts and activation of BCL-2.

31 March 2020

1 reference

EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency

31 March 2020

1 reference

EBV persistence in memory B cells in vivo.

31 March 2020

1 reference

Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells

31 March 2020

1 reference

The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell

31 March 2020

1 reference

The dispersal of mucosal memory B cells: evidence from persistent EBV infection.

31 March 2020

1 reference

Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection

31 March 2020

1 reference

Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease

31 March 2020

1 reference

Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma

31 March 2020

1 reference

Molecular histogenesis of posttransplantation lymphoproliferative disorders

31 March 2020

1 reference

Epstein-barr virus-associated malignancies: epidemiologic patterns and etiologic implications

31 March 2020

1 reference

Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells.

31 March 2020

1 reference

Molecular biology of Hodgkin's lymphoma

31 March 2020

1 reference

Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma

31 March 2020

1 reference

c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1.

31 March 2020

1 reference

Burkitt lymphoma in the mouse.

31 March 2020

1 reference

Role of genetic and epigenetic changes in Burkitt lymphoma

31 March 2020

1 reference

Epstein-Barr virus and the somatic hypermutation of immunoglobulin genes in Burkitt's lymphoma cells

31 March 2020

1 reference

Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.

31 March 2020

1 reference

Antagonistic effects of c-myc and Epstein-Barr virus latent genes on the phenotype of human B cells

31 March 2020

1 reference

Epstein-Barr virus nuclear antigen 1 activates transcription from episomal but not integrated DNA and does not alter lymphocyte growth

31 March 2020

1 reference

Frequent expansion of Epstein-Barr virus (EBV) infected cells in germinal centres of tonsils from an area with a high incidence of EBV-associated lymphoma

31 March 2020

1 reference

T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections

31 March 2020

1 reference

Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma

31 March 2020

1 reference

Biological aspects of Epstein-Barr virus (EBV)-infected lymphocytes in chronic active EBV infection and associated malignancies

31 March 2020

1 reference

Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease

31 March 2020

1 reference

Epstein-Barr virus in the pathogenesis of NPC.

31 March 2020

1 reference

Epidemiology of nasopharyngeal carcinoma.

31 March 2020

1 reference

The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation

31 March 2020

1 reference

Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma

31 March 2020

1 reference

Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein

31 March 2020

1 reference

Loss of p16/CDKN2A tumor suppressor protein in gastric adenocarcinoma is associated with Epstein-Barr virus and anatomic location in the body of the stomach

31 March 2020

1 reference

Epstein-barr virus-positive gastric carcinoma has a distinct protein expression profile in comparison with epstein-barr virus-negative carcinoma

31 March 2020

1 reference

Epstein-Barr virus in gastric carcinomas and gastric stump carcinomas: a late event in gastric carcinogenesis.

31 March 2020

1 reference

Detection of Epstein-Barr virus in invasive breast cancers.

31 March 2020

1 reference

Detection of Epstein-Barr virus (EBV) in hepatocellular carcinoma tissue: a novel EBV latency characterized by the absence of EBV-encoded small RNA expression

31 March 2020

1 reference

Efficacy of targeted FasL in nasopharyngeal carcinoma

31 March 2020

1 reference

Virally targeted therapies for EBV-associated malignancies

31 March 2020

1 reference

Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas

31 March 2020

1 reference

DNA methylation and the Epstein-Barr virus

31 March 2020

1 reference

Azacitidine induces demethylation of the Epstein-Barr virus genome in tumors.

31 March 2020

1 reference

Eradication of latent Epstein-Barr virus by hydroxyurea alters the growth-transformed cell phenotype

31 March 2020

1 reference

Epstein-Barr virus-targeted therapy for AIDS-related primary lymphoma of the central nervous system

31 March 2020

1 reference

Phenotypic knock-out of the latent membrane protein 1 of Epstein-Barr virus by an intracellular single-chain antibody

31 March 2020

1 reference

Inhibition of Epstein-Barr virus-induced growth proliferation by a nuclear antigen EBNA2-TAT peptide

31 March 2020

1 reference

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

31 March 2020

1 reference

Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.

31 March 2020

1 reference

Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells

31 March 2020

1 reference

Expansion of EBV latent membrane protein 2a specific cytotoxic T cells for the adoptive immunotherapy of EBV latency type 2 malignancies: influence of recombinant IL12 and IL15

31 March 2020

1 reference

Epstein-Barr nuclear antigen 1-specific CD4(+) Th1 cells kill Burkitt's lymphoma cells

31 March 2020

1 reference

A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells

31 March 2020

1 reference

DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

31 March 2020

1 reference

Epstein-Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes

31 March 2020

1 reference

Survival and clonal expansion of mutating "forbidden" (immunoglobulin receptor-deficient) epstein-barr virus-infected b cells in angioimmunoblastic t cell lymphoma.

31 March 2020

1 reference

Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma

31 March 2020

1 reference

Genetic and epigenetic changes in nasopharyngeal carcinoma.

31 March 2020

1 reference

In vitro production of stable Epstein-Barr virus-positive epithelial cell clones which resemble the virus:cell interaction observed in nasopharyngeal carcinoma

31 March 2020

1 reference

31 March 2020

1 reference

Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway

31 March 2020

1 reference

Epstein-Barr virus coopts lipid rafts to block the signaling and antigen transport functions of the BCR.

31 March 2020

1 reference

The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domain-containing ubiquitin-protein ligases

31 March 2020

1 reference

Epstein-Barr virus latent membrane protein 2A regulates c-Jun protein through extracellular signal-regulated kinase

31 March 2020

1 reference

Epstein-Barr virus and oncogenesis: from latent genes to tumours

31 March 2020

1 reference

Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23

31 March 2020

1 reference

7 January 2021

The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation

1 reference

7 January 2021

A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jkappa

1 reference

7 January 2021

Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription

1 reference

7 January 2021

Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus.

1 reference

7 January 2021

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15510157

Identifiers

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

445349

1028398461

0 references

445349

1 reference

Consolidated OpenCitations Corpus – April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15510157

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017